Latin Manharlal Chat
BSE Prices delayed by 5 minutes...
     Prices as on Dec 02, 2021 - 3:59PM     
  ABB India 2113.25 [ 4.63% ]
  ACC 2265.95 [ 0.60% ]
  Axis Bank Ltd. 676.05 [ -0.55% ]
  Bank of Baroda 88.1 [ 0.51% ]
  Bharti Airtel 732.15 [ 1.55% ]
  Cipla 921.45 [ -0.68% ]
  Coal India 159.25 [ 2.21% ]
  Colgate Palm. 1440.65 [ 0.80% ]
  Dabur India 579.8 [ 0.53% ]
  DLF Ltd. 386 [ 0.77% ]
  GAIL (India) 131.8 [ 0.92% ]
  Grasim Inds. 1725.2 [ 2.64% ]
  HDFC 2809.15 [ 3.92% ]
  HDFC Bank 1525.65 [ 1.40% ]
  Hero MotoCorp 2477.3 [ 1.28% ]
  Hindalco Indus. 432 [ 1.79% ]
  ICICI Bank 722.55 [ -0.78% ]
  IDFC L 51.9 [ -0.38% ]
  IndusInd Bank 945.5 [ 1.20% ]
  Infosys 1748.25 [ 1.91% ]
  ITC Ltd. 225.45 [ 1.58% ]
  Jindal St & Pwr 355.7 [ 2.45% ]
  L&T 1792.2 [ 0.35% ]
  Lupin Ltd. 875.7 [ 0.51% ]
  Mahi. & Mahi 848.9 [ 1.67% ]
  MTNL 18.9 [ 1.89% ]
  Nestle India 19430 [ 0.21% ]
  NIIT Ltd. 405.8 [ 0.78% ]
  NMDC Ltd. 141.45 [ 2.69% ]
  NTPC 128.8 [ 0.86% ]
  ONGC 143.95 [ 1.23% ]
  Punj. NationlBak 38.5 [ 0.65% ]
  Reliance Inds. 2483.8 [ 0.69% ]
  SBI 477.05 [ 0.37% ]
  Vedanta 338.1 [ -2.65% ]
  Sun Pharma. 768.55 [ 3.11% ]
  Tata Chemicals 900.3 [ 1.92% ]
  Tata Motors Ltd. 479 [ 0.77% ]
  Tata Steel 1112.8 [ 2.80% ]
  Tata Power Co. 226.35 [ 0.51% ]
  Tech Mahindra 1629.65 [ 2.60% ]
  United Spirits 887.7 [ 1.61% ]
  Wipro 646.75 [ 1.88% ]

Company Information

Home » Market » Company Information

Samrat Pharmachem Ltd.

Dec 02, 04:00
235.35 -2.65 ( -1.11 %)
 
VOLUME : 2419
Prev. Close 238.00
Open Price 241.00
TODAY'S LOW / HIGH
232.40
 
 
 
241.90
Bid PRICE (QTY.) 0.00 (0)
Offer PRICE (Qty.) 0.00 (0)
52 WK LOW / HIGH
113.00
 
 
 
304.95
Samrat Pharmachem Ltd. is not traded in NSE
Company Information Menu

Search Company

Market Cap. ( ₹ ) 72.72 Cr. P/BV 2.45 Book Value ( ₹ ) 95.92
52 Week High/Low ( ₹ ) 305/113 FV/ML 10/1 P/E(X) 13.63
Bookclosure 31/12/2020 TTM EPS ( ₹ ) 22.13 Div Yield (%) 0.00
AUDITOR'S REPORT
You can view full text of the latest Director's Report for the company.
Year End :2015-03 We have audited the accompanying financial statements of Samrat Pharmachem Limited ("the Company"), which comprise of the Balance Sheet as at March 31, 2015, and the Statement of Profit and Loss, and Cash Flow Statement of the Company for the year ended on that date, and a summary of significant accounting policies and other explanatory information.

Management's Responsibility for the Financial Statements

The Company's Board of Directors is responsible for the matters stated in Section 134 (5) of the Companies Act, 2013 ("the Act") with respect to the preparation of these standalone financial statements that give a true and fair view of the financial position, financial performance and cash flows of the Company in accordance with the accounting principles generally accepted in India, including the Accounting Standards specified under Section 133 of the Act, read with Rule 7 of the Companies (Accounts) Rules, 2014. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

Auditors' Responsibility

Our responsibility is to express an opinion on these financial statements based on our audit. We have taken into account the provisions of the Act, the accounting and auditing standards and matters which are required to be included in the audit report under the provisions of the Act and the Rules made thereunder. We conducted our audit in accordance with the Standards on Auditing specified under Section 143(10) of the Act. Those Standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor's judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal financial control relevant to the Company's preparation of the financial statements that give a true and fair view in order to design audit procedures that are appropriate in the circumstances. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of the accounting estimates made by Company's Directors, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, and to the best of our information, and according to the explanations given to us, the financial statements give the information required by the Act in the manner so required and give a true and fair view in conformity with the accounting principles generally accepted in India:

(i) in case of the Balance Sheet, of the state of affairs of the Company as at 31st March 2015;

(ii) in case of Statement of Profit and Loss, of the profit of the Company for the year ended on that date.

(iii) in case of cash flow statement, of cash flow of the Company for the year ended on that date.

Report on Other Legal and Regulatory Requirements

As required by Section143 (3) of the Act, we report that:

(a) we have sought and obtained al l the information and explanation, which to the best of our knowledge and belief were necessary for the purpose of our audit;

(b) in our opinion, proper books of account as required by law have been kept by the Company so far as appears from our examination of those books;

(c) the Balance Sheet and Statement of Profit and Loss, and the Cash Flow Statement dealt with by this Report are in agreement with the books of account;

(d) ln our opinion, the aforesaid financial statements comply with the Accounti ng Standards specified under Section 133 of the Act, read with Rule 7 of the Companies (Accounts) Rules, 2014.

(e) on the basis of written representations received from the Directors as on 31st March 2015 taken on record by the board of directors, none of the directors is disqualified as on 31st March 2015 from being appointed as a director in terms of Section 164 (2) of the Act.

(f) With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2014, in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its Standalone Financial Statements - Refer Note 25 (20) to the Financial Statements

ii. The Company has made provisions, as required under the applicable law or accounting standard, for material foreseeable losses, if any, on long-term contracts including derivative contracts.

iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund by the Company.

ANNEXURE REFERRED TO IN REPORT ON OTHER LEGAL AND REGULATORY REQUIREMENTS OF OUR REPORT OF EVEN DATE

IN CASE OF Samrat Pharmachem Limited

(i) (a) The Company is maintaining proper records showing full particulars of, including quantitative details and situation, of fixed assets.

(b) The management at reasonable intervals has verified the fixed assets. We have been informed that, no material discrepancies on such verification have been noticed.

(ii) (a) As per the records maintained, the management has conducted verification of inventory at reasonable intervals.

(b) In our view, the procedures of physical verification of inventory followed by the management are reasonable and adequate in relation to the size of the Company and nature of its business.

(c) In our view, the Company has maintained proper records of inventory. The discrepancies noticed on physical verification of stocks as compared to the book records have been properly dealt with in the books of account on a periodical intervals.

(iii) (a) The Company has not granted any loans, secured or unsecured to companies, firms or other parties covered in the register maintained under section 189 of the Act.

(b) Since no loans are granted, the sub-clause dealing with receipt of the principal amount and interest on regular basis is not applicable.

(c) Since no loans are granted, the sub-clause dealing with overdue amount more than rupees one lakh is not applicable.

(iv) In our view, there is an adequate internal control system commensurate with the size of the Company and nature of its business, for the purchase of inventory and fixed assets, and for sale of goods and services. In our view, there has been no continuing failure to correct major weakness in internal control systems of the Company.

(v) The Company has not accepted any deposits from public within the meaning of the provisions of section 73 or any other provisions of the Companies Act, 2013 and the rules made there under. We have been informed by the management that there has been no order passed by the Company law Board or National Company Law Tribunal or Reserve Bank of India or any Court or any other Tribunal on the Company with respect to compliance of the provisions of section 73 or any other provisions of the Companies Act 2013.

(vi) We have been informed by the management that, the Central Government has not prescribed the method of maintenance of cost records u/s. 148 (1) of the Companies Act, 2013 to the industry to which the Company pertains.

(vii) (a) We have been informed by the management that, the Company is generally regular in depositing all undisputed statutory dues with the appropriate authorities and there have been no material arrears of outstanding dues as at the last day of this financial year for more than six months from the date they became payable .

(b) In our opinion and according to the information and explanation given to us, there are no undisputed dues of Income tax, Sales tax, Wealth Tax, and Service tax, Custom Duty, Excise Duty or Cess, or value added tax as applicable to it which have not been deposited on account of any dispute except mentioned hereunder:

Assessment Year     Type of Demand    Amount in Dispute    Forum where
                                            (INR)          Dispute is
                                                           pending

2011-12               Income-tax       3,580,450.00        Commissioner
                                                           of Income-
                                                           tax (Appeal)
(c) In our opinion, the company is not required to transfer any amount to investor education and protection fund in accordance with the relevant provision of the Companies Act, 1956 (1 of 1956) and rules made thereunder.

(viii) There are no accumulated losses at the end of the financial year. The Company has not reported any cash losses during the year or immediately preceding financial year.

(ix) As informed to us by the management, the Company has not defaulted in repayment of any dues to financial institution or banks; whereas there are no debenture holders

(x) The management has informed us that, the Company has not given any guarantee for loans taken by others from any bank or financial institutions.

(xi) As per the explanation given by the management, the term loans were applied for the purposes for which they were obtained.

(xii) As informed by the management, there has not been noticed or reported any fraud on or by the Company during the year.

For SHAH, SHAH & SHAH CHARTERED ACCOUNTANTS

(Mehul Shah) PARTNER Mumbai: 30 May 2015 M. No.049361 FRN: 116457W